Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis

Calcific aortic valve stenosis (AS) is the most prevalent valvular heart disease in high-income countries [(1)][1], and currently there is no pharmacotherapy known to prevent its progression. Oral anticoagulants are the benchmark for preventing thromboembolic complications, especially in condition